Table of Contents

2019-2024 Global Oral Contraceptive Drugs Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Oral Contraceptive Drugs Consumption 2014-2024
  • 2.1.2 Oral Contraceptive Drugs Consumption CAGR by Region
• 2.2 Oral Contraceptive Drugs Segment by Type
  • 2.2.1 Long-acting Contraceptives
  • 2.2.2 Short-acting Contraceptives
  • 2.2.3 Emergency Contraceptives
• 2.3 Oral Contraceptive Drugs Consumption by Type
  • 2.3.1 Global Oral Contraceptive Drugs Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Oral Contraceptive Drugs Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Oral Contraceptive Drugs Sale Price by Type (2014-2019)
• 2.4 Oral Contraceptive Drugs Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Pharmacy
  • 2.4.3 Other
• 2.5 Oral Contraceptive Drugs Consumption by Application
  • 2.5.1 Global Oral Contraceptive Drugs Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Oral Contraceptive Drugs Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Oral Contraceptive Drugs Sale Price by Application (2014-2019)

3 Global Oral Contraceptive Drugs by Players

• 3.1 Global Oral Contraceptive Drugs Sales Market Share by Players
  • 3.1.1 Global Oral Contraceptive Drugs Sales by Players (2017-2019)
  • 3.1.2 Global Oral Contraceptive Drugs Sales Market Share by Players (2017-2019)
• 3.2 Global Oral Contraceptive Drugs Revenue Market Share by Players
  • 3.2.1 Global Oral Contraceptive Drugs Revenue by Players (2017-2019)
  • 3.2.2 Global Oral Contraceptive Drugs Revenue Market Share by Players (2017-2019)
• 3.3 Global Oral Contraceptive Drugs Sale Price by Players
• 3.4 Global Oral Contraceptive Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Oral Contraceptive Drugs Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Oral Contraceptive Drugs Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Oral Contraceptive Drugs by Regions

• 4.1 Oral Contraceptive Drugs by Regions
  • 4.1.1 Global Oral Contraceptive Drugs Consumption by Regions
  • 4.1.2 Global Oral Contraceptive Drugs Value by Regions
• 4.2 Americas Oral Contraceptive Drugs Consumption Growth
• 4.3 APAC Oral Contraceptive Drugs Consumption Growth
• 4.4 Europe Oral Contraceptive Drugs Consumption Growth
• 4.5 Middle East & Africa Oral Contraceptive Drugs Consumption Growth

5 Americas

• 5.1 Americas Oral Contraceptive Drugs Consumption by Countries
  • 5.1.1 Americas Oral Contraceptive Drugs Consumption by Countries (2014-2019)
  • 5.1.2 Americas Oral Contraceptive Drugs Value by Countries (2014-2019)
• 5.2 Americas Oral Contraceptive Drugs Consumption by Type
• 5.3 Americas Oral Contraceptive Drugs Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Oral Contraceptive Drugs Consumption by Countries
  • 6.1.1 APAC Oral Contraceptive Drugs Consumption by Countries (2014-2019)
  • 6.1.2 APAC Oral Contraceptive Drugs Value by Countries (2014-2019)
• 6.2 APAC Oral Contraceptive Drugs Consumption by Type
• 6.3 APAC Oral Contraceptive Drugs Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Oral Contraceptive Drugs by Countries
  • 7.1.1 Europe Oral Contraceptive Drugs Consumption by Countries (2014-2019)
  • 7.1.2 Europe Oral Contraceptive Drugs Value by Countries (2014-2019)
• 7.2 Europe Oral Contraceptive Drugs Consumption by Type
• 7.3 Europe Oral Contraceptive Drugs Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Oral Contraceptive Drugs by Countries
  • 8.1.1 Middle East & Africa Oral Contraceptive Drugs Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Oral Contraceptive Drugs Value by Countries (2014-2019)
• 8.2 Middle East & Africa Oral Contraceptive Drugs Consumption by Type
• 8.3 Middle East & Africa Oral Contraceptive Drugs Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Oral Contraceptive Drugs Distributors
• 10.3 Oral Contraceptive Drugs Customer

11 Global Oral Contraceptive Drugs Market Forecast

• 11.1 Global Oral Contraceptive Drugs Consumption Forecast (2019-2024)
• 11.2 Global Oral Contraceptive Drugs Forecast by Regions
  • 11.2.1 Global Oral Contraceptive Drugs Forecast by Regions (2019-2024)
  • 11.2.2 Global Oral Contraceptive Drugs Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Oral Contraceptive Drugs Forecast by Type
• 11.8 Global Oral Contraceptive Drugs Forecast by Application

12 Key Players Analysis

• 12.1 Bayer
  • 12.1.1 Company Details
  • 12.1.2 Oral Contraceptive Drugs Product Offered
  • 12.1.3 Bayer Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bayer News
• 12.2 Pfizer
  • 12.2.1 Company Details
  • 12.2.2 Oral Contraceptive Drugs Product Offered
  • 12.2.3 Pfizer Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Pfizer News
• 12.3 Teva Pharmaceutical
  • 12.3.1 Company Details
  • 12.3.2 Oral Contraceptive Drugs Product Offered
  • 12.3.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Teva Pharmaceutical News
• 12.4 Merck
  • 12.4.1 Company Details
  • 12.4.2 Oral Contraceptive Drugs Product Offered
  • 12.4.3 Merck Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Merck News
• 12.5 Actavis
  • 12.5.1 Company Details
  • 12.5.2 Oral Contraceptive Drugs Product Offered
  • 12.5.3 Actavis Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Actavis News
• 12.6 Johnson & Johnson
  • 12.6.1 Company Details
  • 12.6.2 Oral Contraceptive Drugs Product Offered
  • 12.6.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Johnson & Johnson News
• 12.7 Gedeon Richter
  • 12.7.1 Company Details
  • 12.7.2 Oral Contraceptive Drugs Product Offered
  • 12.7.3 Gedeon Richter Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Gedeon Richter News
• 12.8 Novo Nordisk A/S
  • 12.8.1 Company Details
  • 12.8.2 Oral Contraceptive Drugs Product Offered
  • 12.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Novo Nordisk A/S News
• 12.9 ZiZhu
  • 12.9.1 Company Details
  • 12.9.2 Oral Contraceptive Drugs Product Offered
  • 12.9.3 ZiZhu Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 ZiZhu News
• 12.10 Baijingyu
  • 12.10.1 Company Details
  • 12.10.2 Oral Contraceptive Drugs Product Offered
  • 12.10.3 Baijingyu Oral Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Baijingyu News
• 12.11 Huazhong

13 Research Findings and Conclusion

Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.

According to this study, over the next five years the Oral Contraceptive Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Oral Contraceptive Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Contraceptive Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Oral Contraceptive Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Oral Contraceptive Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Oral Contraceptive Drugs market by identifying its various subsegments.
Focuses on the key global Oral Contraceptive Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oral Contraceptive Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oral Contraceptive Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.